Cargando…

Risk factors for type 1 and type 2 myocardial infarction

AIMS: Whilst the risk factors for type 1 myocardial infarction due to atherosclerotic plaque rupture and thrombosis are established, our understanding of the factors that predispose to type 2 myocardial infarction during acute illness is still emerging. Our aim was to evaluate and compare the risk f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wereski, Ryan, Kimenai, Dorien M, Bularga, Anda, Taggart, Caelan, Lowe, David J, Mills, Nicholas L, Chapman, Andrew R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757580/ https://www.ncbi.nlm.nih.gov/pubmed/34431993 http://dx.doi.org/10.1093/eurheartj/ehab581

Ejemplares similares

Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction
por: Wereski, Ryan, et al.
Publicado: (2021)

Improving Risk Stratification for Patients With Type 2 Myocardial Infarction
por: Taggart, Caelan, et al.
Publicado: (2023)

Influence of Age on the Diagnosis of Myocardial Infarction
por: Lowry, Matthew T.H., et al.
Publicado: (2022)

Assessment of Oxygen Supply-Demand Imbalance and Outcomes Among Patients With Type 2 Myocardial Infarction: A Secondary Analysis of the High-STEACS Cluster Randomized Clinical Trial
por: Bularga, Anda, et al.
Publicado: (2022)

Troponin in early presenters to rule out myocardial infarction
por: Lowry, Matthew T H, et al.
Publicado: (2023)

Diagnosis, Investigation and Management of Patients with Acute and Chronic Myocardial Injury
por: Taggart, Caelan, et al.
Publicado: (2021)

Sex differences in investigations and outcomes among patients with type 2 myocardial infarction
por: Kimenai, Dorien M, et al.
Publicado: (2021)

Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study
por: Bularga, Anda, et al.
Publicado: (2022)

Impact of Patient Selection on Performance of an Early Rule-Out Pathway for Myocardial Infarction: From Research to the Real World
por: Bularga, Anda, et al.
Publicado: (2023)

Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction
por: Hung, John, et al.
Publicado: (2020)

Ambient Temperature and Myocardial Infarction: Who Is at Risk?
por: Lowry, Matthew T.H., et al.
Publicado: (2023)

Mechanisms of Myocardial Injury in COVID-19
por: Bularga, Anda, et al.
Publicado: (2021)

High-Sensitivity Cardiac Troponin Concentrations at Presentation in Patients With ST-Segment Elevation Myocardial Infarction
por: Wereski, Ryan, et al.
Publicado: (2020)

Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction
por: Lee, Kuan Ken, et al.
Publicado: (2021)

Risk Stratification Using High-Sensitivity Cardiac Troponin T in Patients With Suspected Acute Coronary Syndrome
por: Chapman, Andrew R., et al.
Publicado: (2020)

Troponin in acute chest pain to risk stratify and guide effective use of computed tomography coronary angiography (TARGET-CTCA): a randomised controlled trial
por: Lee, Kuan Ken, et al.
Publicado: (2023)

Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury
por: DeFilippis, Andrew P., et al.
Publicado: (2019)

Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury
por: Chapman, Andrew R., et al.
Publicado: (2018)

Computed tomography coronary angiography in non-ST-segment elevation myocardial infarction
por: Wang, Kang-Ling, et al.
Publicado: (2022)

A Proposal for Modest Revision of the Definition of Type 1 and Type 2 Myocardial Infarction
por: de Lemos, James A., et al.
Publicado: (2019)

Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection
por: Bularga, Anda, et al.
Publicado: (2022)

Validation of the myocardial-ischaemic-injury-index machine learning algorithm to guide the diagnosis of myocardial infarction in a heterogenous population: a prespecified exploratory analysis
por: Doudesis, Dimitrios, et al.
Publicado: (2022)

Enhanced Computed Tomography of Type 2 Myocardial Infarction
por: Miyagawa, Masatsugu, et al.
Publicado: (2021)

Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial
por: Lee, Kuan Ken, et al.
Publicado: (2023)

High-sensitivity cardiac troponin I assays in the diagnosis of acute myocardial infarction
por: Chapman, Andrew R, et al.
Publicado: (2017)

Assessment and classification of patients with myocardial injury and infarction in clinical practice
por: Chapman, Andrew R, et al.
Publicado: (2017)

A sex-specific prediction model is not enough to achieve equality for women in preventative cardiovascular medicine
por: Kimenai, Dorien M., et al.
Publicado: (2021)

High-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action
por: Chapman, Andrew R, et al.
Publicado: (2020)

Sensitive Troponin Assay and the Classification of Myocardial Infarction
por: Shah, Anoop S.V., et al.
Publicado: (2015)

Trends in conventional cardiovascular risk factors and myocardial infarction subtypes among young Chinese men with a first acute myocardial infarction
por: Zhang, Min, et al.
Publicado: (2021)

Ejection fraction, B‐type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure
por: Greenberg, Barry, et al.
Publicado: (2019)

Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations
por: Doudesis, Dimitrios, et al.
Publicado: (2023)

Clinical outcomes in patients with acute myocardial infarction treated with primary percutaneous coronary intervention stratified according to duration of pain-to-balloon time and type of myocardial infarction
por: Staszczak, Bartłomiej, et al.
Publicado: (2023)

Implementation of an early rule-out pathway for myocardial infarction using a high-sensitivity cardiac troponin T assay
por: Sandeman, Dennis, et al.
Publicado: (2021)

Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort
por: Welsh, Paul, et al.
Publicado: (2022)

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
por: White, Harvey D, et al.
Publicado: (2019)

Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries
por: Puymirat, Etienne, et al.
Publicado: (2018)

Myocardial infarction risk and tamoxifen therapy for breast cancer
por: Geiger, A M, et al.
Publicado: (2005)

Management and outcome across the spectrum of high‐risk patients with myocardial infarction according to the thrmobolysis in myocardial infarction (TIMI) risk‐score for secondary prevention
por: Grinberg, Tzlil, et al.
Publicado: (2021)

Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy
por: Reid, Christopher, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_obu43ui9cgm8l33ug419e115i8